1296 related articles for article (PubMed ID: 11100379)
1. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
3. Gastric carcinoma: does lymph node dissection alter survival?
Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
[TBL] [Abstract][Full Text] [Related]
4. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
5. Limited effectiveness of extended lymph-node dissection for node-negative patients with proximal gastric cancer.
Kikuchi S; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Sato K; Kakita A
Anticancer Res; 2001; 21(2B):1359-62. PubMed ID: 11396213
[TBL] [Abstract][Full Text] [Related]
6. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.
Kasakura Y; Mochizuki F; Wakabayashi K; Kochi M; Fujii M; Takayama T
J Surg Res; 2002 Apr; 103(2):252-9. PubMed ID: 11922742
[TBL] [Abstract][Full Text] [Related]
8. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
9. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
[TBL] [Abstract][Full Text] [Related]
10. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
11. [Rational evaluation of different lymph node dissection].
Chen JQ; Wang SB; Qi CL
Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):110-3, 128. PubMed ID: 7767766
[TBL] [Abstract][Full Text] [Related]
12. Lymph node metastasis with adenocarcinoma of the gastric cardia: clinicopathological analysis and indication for D1 dissection.
Shimada H; Suzuki T; Nakajima K; Hori S; Hayashi H; Takeda A; Arima M; Gunji Y; Koide Y; Ochiai T
Int Surg; 1999; 84(1):13-7. PubMed ID: 10421011
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of splenectomy on advanced proximal gastric cancer with No. 10 lymph node metastasis.
Huang CM; Wang JB; Lu HS; Zheng CH; Li P; Xie JW; Zhang XF
Chin Med J (Engl); 2009 Nov; 122(22):2757-62. PubMed ID: 19951610
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
15. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
[TBL] [Abstract][Full Text] [Related]
16. Perigastric lymph node status as a prognostic indicator in patients with gastric cancer.
Adachi Y; Suematsu T; Shiraishi N; Tanimura H; Morimoto A; Kitano S
Br J Surg; 1998 Sep; 85(9):1281-4. PubMed ID: 9752878
[TBL] [Abstract][Full Text] [Related]
17. [Five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma].
Yan-Quiroz EF; Díaz-Plasencia JA; Burgos-Chávez OA; Rojas-Vergara AM; Santillán-Medina J; Vilela-Guillén ES; Balmaceda-Fraselle T
Rev Gastroenterol Peru; 2003; 23(3):184-91. PubMed ID: 14532919
[TBL] [Abstract][Full Text] [Related]
18. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
[TBL] [Abstract][Full Text] [Related]
19. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of extended lymphadenectomy in the noncurative gastrectomy for advanced gastric cancer.
Hanazaki K; Sodeyama H; Mochizuki Y; Machida T; Yokoyama S; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T; Amano J
Hepatogastroenterology; 1999; 46(28):2677-82. PubMed ID: 10522064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
